Observational studyMedicine2018

Efficacy and Safety of apatinib in patients with intermediate/advanced hepatocellular carcinoma: A prospective observation study.

Wen-Chang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.